基于甘草酸及其衍生物开发新型抗病毒药物的前景（综述）
Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review).
作者信息
Baltina L A, Kondratenko R M, Baltina L A, Plyasunova O A, Pokrovskii A G, Tolstikov G A
机构信息
1Institute of Organic Chemistry, UfaScientific Center, Russian Academy of Sciences, Ufa, Bashkortostan Russia.
2Bashkir State Medical University, Ufa, Bashkortostan Russia.
出版信息
Pharm Chem J. 2009;43(10):539-548. doi: 10.1007/s11094-010-0348-2. Epub 2010 Feb 4.
Abstract
The review is devoted to the problem of creating new antiviral drugs based on glycyrrhizic acid (GA), the major triterpene glycoside extracted from roots of common and Ural licorice ( L. and Fisher, respectively). Published data on the natural GA sources, antiviral activity of GA and its derivatives, clinical applications of GA-based drugs, and the properties of GA-containing biologically active nutrient additives are summarized. Possible mechanisms of the antiviral activity of GA and its derivatives are examined. It is shown that chemical modification of GA is a promising way of designing new highly active antiviral drugs for the prophylaxis and treatment of HIV, hepatitis B and C, corona-virus, and herpes simplex virus infections.
摘要
这篇综述致力于基于甘草酸（GA）开发新型抗病毒药物的问题，甘草酸是从普通甘草和乌拉尔甘草（分别为甘草和光果甘草）根部提取的主要三萜糖苷。总结了关于天然GA来源、GA及其衍生物的抗病毒活性、GA类药物的临床应用以及含GA的生物活性营养添加剂特性的已发表数据。研究了GA及其衍生物抗病毒活性的可能机制。结果表明，GA的化学修饰是设计用于预防和治疗HIV、乙型和丙型肝炎、冠状病毒以及单纯疱疹病毒感染的新型高活性抗病毒药物的一种有前景的方法。
相似文献
1
Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review).基于甘草酸及其衍生物开发新型抗病毒药物的前景（综述）
Pharm Chem J. 2009;43(10):539-548. doi: 10.1007/s11094-010-0348-2. Epub 2010 Feb 4.
2
Synthesis and antiviral activity of 18α-glycyrrhizic acid and its esters.18α-甘草酸及其酯的合成与抗病毒活性
Pharm Chem J. 2010;44(6):299-302. doi: 10.1007/s11094-010-0454-1. Epub 2010 Oct 27.
3
Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.甘草酸作为甘草抗病毒成分对肠道病毒 71 型和柯萨奇病毒 A16 手足口病的作用。
J Ethnopharmacol. 2013 May 2;147(1):114-21. doi: 10.1016/j.jep.2013.02.017. Epub 2013 Feb 27.
4
Research Progress of Glycyrrhizic Acid on Antiviral Activity.甘草酸抗病毒活性的研究进展。
Mini Rev Med Chem. 2019;19(10):826-832. doi: 10.2174/1389557519666190119111125.
5
Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine.甘草酸的化学修饰作为一种获取新型药用生物活性化合物的途径。
Curr Med Chem. 2003 Jan;10(2):155-71. doi: 10.2174/0929867033368538.
6
Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.甘草次酸衍生物作为寨卡病毒抑制剂的研究：体外合成与抗病毒活性。
Bioorg Med Chem. 2021 Jul 1;41:116204. doi: 10.1016/j.bmc.2021.116204. Epub 2021 May 10.
7
Glycyrrhizic acid in the treatment of liver diseases: literature review.甘草酸治疗肝脏疾病：文献综述
Biomed Res Int. 2014;2014:872139. doi: 10.1155/2014/872139. Epub 2014 May 13.
8
A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide.甘草酸、甘草次酸和甘草次酸单葡萄糖醛酸苷的抗病毒活性综述
Pharmaceuticals (Basel). 2023 Apr 23;16(5):641. doi: 10.3390/ph16050641.
9
Synergistic antiviral activity of Lactobacillus acidophilus and Glycyrrhiza glabra against Herpes Simplex-1 Virus (HSV-1) and Vesicular Stomatitis Virus (VSV): experimental and In Silico insights.嗜酸乳杆菌和甘草联合抗单纯疱疹病毒-1（HSV-1）和水疱性口炎病毒（VSV）的抗病毒活性：实验和计算见解。
BMC Microbiol. 2023 Jun 30;23(1):173. doi: 10.1186/s12866-023-02911-z.
10
Broad Antiviral Spectrum of Glycyrrhizic Acid for Human and Veterinary Medicine: Reality or Fiction?甘草酸在人医和兽医领域的广谱抗病毒作用：现实还是虚构？
Intervirology. 2023;66(1):41-53. doi: 10.1159/000528198. Epub 2022 Dec 1.
引用本文的文献
1
Development of antibacterial nanocomposites by combination of bacterial cellulose/chitin nanofibrils and all-natural bioactive nanoparticles.通过细菌纤维素/几丁质纳米纤维与全天然生物活性纳米颗粒相结合制备抗菌纳米复合材料。
Curr Res Food Sci. 2023 Sep 1;7:100584. doi: 10.1016/j.crfs.2023.100584. eCollection 2023.
2
Effect of Glycyrrhetic Acid Derivatives on Regulation of Thymocyte Volume.甘草次酸衍生物对胸腺细胞体积调节的影响。
Bull Exp Biol Med. 2023 May;175(1):27-31. doi: 10.1007/s10517-023-05804-3. Epub 2023 Jun 20.
3
Glycyrrhizic Acid Derivatives Bearing Amino Acid Residues in the Carbohydrate Part as Dengue Virus E Protein Inhibitors: Synthesis and Antiviral Activity.糖基部分带有氨基酸残基的甘草次酸衍生物作为登革病毒 E 蛋白抑制剂：合成与抗病毒活性。
Int J Mol Sci. 2022 Sep 7;23(18):10309. doi: 10.3390/ijms231810309.
4
Synthesis, Antiviral, and Antibacterial Activity of the Glycyrrhizic Acid and Glycyrrhetinic Acid Derivatives.甘草酸和甘草次酸衍生物的合成、抗病毒及抗菌活性
Russ J Bioorg Chem. 2022;48(5):906-918. doi: 10.1134/S1068162022050132. Epub 2022 Jul 28.
5
Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and insights.丹参酮IIA、鼠尾草酸、迷迭香酸、丹酚酸、黄芩素和甘草次酸在计算和深入研究方面的抗SARS-CoV-2活性。
RSC Adv. 2021 Sep 1;11(47):29267-29286. doi: 10.1039/d1ra05268c.
6
Revisiting liquorice ( L.) as anti-inflammatory, antivirals and immunomodulators: Potential pharmacological applications with mechanistic insight.重新审视甘草（L.）作为抗炎、抗病毒和免疫调节剂：具有机制见解的潜在药理学应用。
Phytomed Plus. 2022 Feb;2(1):100206. doi: 10.1016/j.phyplu.2021.100206. Epub 2021 Dec 18.
7
The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions.甘草酸和甘草提取物在对抗 COVID-19 及其相关病症方面的潜力。
Phytomed Plus. 2021 Aug;1(3):100043. doi: 10.1016/j.phyplu.2021.100043. Epub 2021 Feb 17.
8
Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic.连花清瘟胶囊的见解：一种被重新用于应对新冠疫情的中药。
Phytomed Plus. 2021 May;1(2):100027. doi: 10.1016/j.phyplu.2021.100027. Epub 2021 Jan 16.
9
Can Antiviral Activity of Licorice Help Fight COVID-19 Infection?甘草的抗病毒活性能帮助对抗 COVID-19 感染吗？
Biomolecules. 2021 Jun 8;11(6):855. doi: 10.3390/biom11060855.
10
Synthesis of Glycyrrhizic Acid Conjugates with S-Benzyl-L-Cysteine and Their Antiviral Activity.甘草酸与S-苄基-L-半胱氨酸缀合物的合成及其抗病毒活性
Pharm Chem J. 2021;55(3):224-227. doi: 10.1007/s11094-021-02402-3. Epub 2021 Jun 14.
本文引用的文献
1
Viral hepatitis B: established and emerging therapies.乙型病毒性肝炎：既定疗法与新兴疗法
Curr Med Chem. 2008;15(9):930-9. doi: 10.2174/092986708783955383.
2
Small molecule and biologic inhibitors of hepatitis C virus: a symbiotic approach.丙型肝炎病毒的小分子和生物抑制剂：一种共生方法。
Mini Rev Med Chem. 2006 Nov;6(11):1263-8. doi: 10.2174/138955706778742786.
3
A novel antiretroviral class (fusion inhibitors) in the management of HIV infection. Present features and future perspectives of enfuvirtide (T-20).一种用于治疗HIV感染的新型抗逆转录病毒药物类别（融合抑制剂）。恩夫韦肽（T-20）的当前特点及未来展望。
Curr Med Chem. 2006;13(20):2369-84. doi: 10.2174/092986706777935069.
4
Natural products to drugs: natural product derived compounds in clinical trials.从天然产物到药物：临床试验中的天然产物衍生化合物
Nat Prod Rep. 2005 Apr;22(2):162-95. doi: 10.1039/b402985m. Epub 2005 Mar 8.
5
Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.甘草酸衍生物对严重急性呼吸综合征冠状病毒的抗病毒活性。
J Med Chem. 2005 Feb 24;48(4):1256-9. doi: 10.1021/jm0493008.
6
[The anti-HIV activity of glycyrrhizic acid penta-O-nicotinate].甘草酸五 - O - 烟酸盐的抗HIV活性
Vestn Ross Akad Med Nauk. 2004(11):42-6.
7
The role of natural product chemistry in drug discovery.天然产物化学在药物发现中的作用。
J Nat Prod. 2004 Dec;67(12):2141-53. doi: 10.1021/np040106y.
8
[The synthesis and antiviral activity of glycyrrhizic acid conjugates with alpha-D-glucosamine and some glycosylamines].甘草酸与α-D-葡萄糖胺及一些糖基胺的缀合物的合成及抗病毒活性
Bioorg Khim. 2004 May-Jun;30(3):308-15. doi: 10.1023/b:rubi.0000030135.97089.37.
9
Variability in the content of active constituents and biological activity of Glycyrrhiza glabra.光果甘草中活性成分含量及生物活性的变异性。
Fitoterapia. 2004 Jun;75(3-4):371-4. doi: 10.1016/j.fitote.2003.12.022.
10
Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review.补充和替代疗法治疗慢性丙型肝炎：一项系统评价
J Hepatol. 2004 Mar;40(3):491-500. doi: 10.1016/j.jhep.2003.11.014.
Zotero 插件